Singapore markets close in 4 hours 41 minutes
Straits Times Index
3,301.49 +8.80 (+0.27%) Nikkei
38,275.29 +1.24 (+0.00%) Hang Seng
18,155.28 +392.25 (+2.21%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,407.41 -2,827.11 (-4.69%) CMC Crypto 200
1,260.91 -78.16 (-5.84%)
Verve Therapeutics, Inc. (VERV)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 502.70M |
| Enterprise value | -46.35M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 32.69 |
| Price/book (mrq) | 0.84 |
| Enterprise value/revenue | -3.94 |
| Enterprise value/EBITDA | 0.21 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.70 |
| 52-week change 3 | -63.21% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 21.42 |
| 52-week low 3 | 5.84 |
| 50-day moving average 3 | 11.22 |
| 200-day moving average 3 | 12.91 |
Share statistics
| Avg vol (3-month) 3 | 1.32M |
| Avg vol (10-day) 3 | 1.1M |
| Shares outstanding 5 | 83.92M |
| Implied shares outstanding 6 | 83.92M |
| Float 8 | 66.88M |
| % held by insiders 1 | 7.62% |
| % held by institutions 1 | 86.89% |
| Shares short (15 Apr 2024) 4 | 15.69M |
| Short ratio (15 Apr 2024) 4 | 9.39 |
| Short % of float (15 Apr 2024) 4 | 24.23% |
| Short % of shares outstanding (15 Apr 2024) 4 | 18.77% |
| Shares short (prior month 15 Mar 2024) 4 | 14.1M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,048.76% |
Management effectiveness
| Return on assets (ttm) | -19.48% |
| Return on equity (ttm) | -34.78% |
Income statement
| Revenue (ttm) | 11.76M |
| Revenue per share (ttm) | 0.18 |
| Quarterly revenue growth (yoy) | 408.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -217.67M |
| Net income avi to common (ttm) | -200.07M |
| Diluted EPS (ttm) | -3.12 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 623.95M |
| Total cash per share (mrq) | 7.46 |
| Total debt (mrq) | 74.91M |
| Total debt/equity (mrq) | 12.49% |
| Current ratio (mrq) | 17.24 |
| Book value per share (mrq) | 7.31 |
Cash flow statement
| Operating cash flow (ttm) | -149.55M |
| Levered free cash flow (ttm) | -110.19M |
© 2024 Yahoo. All rights reserved.